A technique for delineating the unfolding requirements for substrate entry into retrotranslocons during endoplasmic reticulum-associated degradation.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
27 12 2019
Historique:
received: 01 07 2019
revised: 13 11 2019
pubmed: 22 11 2019
medline: 23 6 2020
entrez: 22 11 2019
Statut: ppublish

Résumé

The endoplasmic reticulum-associated degradation (ERAD) pathway mediates the endoplasmic reticulum-to-cytosol retrotranslocation of defective proteins through protein complexes called retrotranslocons. Defective proteins usually have complex conformations and topologies, and it is unclear how ERAD can thread these conformationally diverse protein substrates through the retrotranslocons. Here, we investigated the substrate conformation flexibility necessary for transport via retrotranslocons on the ERAD-L, ERAD-M, and HIV-encoded protein Vpu-hijacked ERAD branches. To this end, we appended various ERAD substrates with specific domains whose conformations were tunable in flexibility or tightness by binding to appropriate ligands. With this technique, we could define the capacity of specific retrotranslocons in disentangling very tight, less tight but well-folded, and unstructured conformations. The Hrd1 complex, the retrotranslocon on the ERAD-L branch, permitted the passage of substrates with a proteinase K-resistant tight conformation, whereas the E3 ligase gp78-mediated ERAD-M allowed passage only of nearly completely disordered but not well-folded substrates and thus may have the least unfoldase activity. Vpu-mediated ERAD, containing a potential retrotranslocon, could unfold well-folded substrates for successful retrotranslocation. However, substrate retrotranslocation in Vpu-mediated ERAD was blocked by enhanced conformational tightness of the substrate. On the basis of these findings, we propose a mechanism underlying polypeptide movement through the endoplasmic reticulum membrane. We anticipate that our biochemical system paves the way for identifying the factors necessary for the retrotranslocation of membrane proteins.

Identifiants

pubmed: 31748412
pii: S0021-9258(20)30027-2
doi: 10.1074/jbc.RA119.010019
pmc: PMC6937559
doi:

Substances chimiques

Human Immunodeficiency Virus Proteins 0
Leupeptins 0
Viral Regulatory and Accessory Proteins 0
vpu protein, Human immunodeficiency virus 1 0
AMFR protein, human EC 2.3.2.27
Receptors, Autocrine Motility Factor EC 2.3.2.27
SYVN1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Proteasome Endopeptidase Complex EC 3.4.25.1
benzyloxycarbonylleucyl-leucyl-leucine aldehyde RF1P63GW3K
Trimetrexate UPN4ITI8T4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20084-20096

Informations de copyright

© 2019 Shi et al.

Références

J Cell Biol. 2010 Jan 25;188(2):223-35
pubmed: 20100910
EMBO J. 1993 Jan;12(1):243-53
pubmed: 8428582
J Biol Chem. 1995 Apr 7;270(14):8172-8
pubmed: 7713922
Cell. 2014 Sep 11;158(6):1375-1388
pubmed: 25215493
Semin Cell Dev Biol. 2019 Sep;93:111-124
pubmed: 30278225
Science. 2019 Aug 2;365(6452):
pubmed: 31249135
Mol Cell. 2010 Nov 24;40(4):671-81
pubmed: 21095592
Nat Cell Biol. 2008 Mar;10(3):272-82
pubmed: 18264092
Plant Cell. 2018 Sep;30(9):2161-2173
pubmed: 30104404
J Virol. 2012 Jan;86(2):757-72
pubmed: 22090097
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
PLoS Biol. 2011 Mar;8(3):e1000605
pubmed: 21468303
Mol Biol Cell. 2010 Dec;21(24):4325-37
pubmed: 20980618
J Biol Chem. 2000 Sep 1;275(35):27447-56
pubmed: 10862611
Eur J Biochem. 1994 Oct 1;225(1):403-9
pubmed: 7925462
J Biol Chem. 2011 Sep 9;286(36):31328-36
pubmed: 21768107
Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8):null
pubmed: 30670468
Cell. 2016 Jul 14;166(2):394-407
pubmed: 27321670
Nat Biotechnol. 2006 Jan;24(1):79-88
pubmed: 16369541
Cell. 2006 Jul 28;126(2):361-73
pubmed: 16873066
Nature. 2010 Aug 26;466(7310):1120-4
pubmed: 20676083
Science. 1996 Jul 12;273(5272):239-42
pubmed: 8662507
PLoS Pathog. 2010 Apr 29;6(4):e1000869
pubmed: 20442859
J Virol. 1992 Dec;66(12):7193-200
pubmed: 1433512
Biochim Biophys Acta. 1994 Jul 20;1207(1):74-9
pubmed: 8043612
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8785-90
pubmed: 17496150
Biochem J. 2017 Feb 15;474(4):445-469
pubmed: 28159894
Nat Microbiol. 2019 May;4(5):813-825
pubmed: 30833724
Mol Cell. 2015 Aug 6;59(3):335-44
pubmed: 26253026
Cell. 2013 Aug 1;154(3):609-22
pubmed: 23890821
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4380-E4388
pubmed: 28512218
PLoS Pathog. 2009 Sep;5(9):e1000574
pubmed: 19730691
Elife. 2015 May 20;4:null
pubmed: 25993558
Annu Rev Biochem. 2018 Jun 20;87:751-782
pubmed: 29394096
Science. 2001 May 25;292(5521):1552-5
pubmed: 11375494
J Cell Biol. 2009 Sep 7;186(5):685-92
pubmed: 19720873
Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57
pubmed: 19002207
Cell Rep. 2018 Feb 27;22(9):2493-2503
pubmed: 29490283
Nat Commun. 2011 Jul 12;2:393
pubmed: 21750546
Nature. 2017 Aug 17;548(7667):352-355
pubmed: 28682307
J Biol Chem. 2003 Feb 28;278(9):6664-72
pubmed: 12482753
Cell. 2006 Sep 8;126(5):995-1004
pubmed: 16959577
Nat Chem Biol. 2009 Jan;5(1):29-36
pubmed: 19029916
PLoS One. 2012;7(9):e43297
pubmed: 22984418
J Virol. 1993 Jul;67(7):3877-84
pubmed: 8510209
Science. 2019 Aug 2;365(6452):502-505
pubmed: 31249134
J Biol Chem. 2014 Jan 3;289(1):1-12
pubmed: 24257748
J Med Chem. 2015 Dec 24;58(24):9480-97
pubmed: 26565666
EMBO J. 2003 Mar 3;22(5):1036-46
pubmed: 12606569
J Biol Chem. 2006 Jun 30;281(26):17545-51
pubmed: 16624807
Curr Opin Cell Biol. 2018 Aug;53:22-28
pubmed: 29719269
Nat Struct Mol Biol. 2014 Apr;21(4):325-35
pubmed: 24699081
Cancer Cell. 2015 Nov 9;28(5):653-665
pubmed: 26555175
J Biol Chem. 2011 Mar 11;286(10):8633-43
pubmed: 21205830
Nature. 1986 Jul 17-23;322(6076):228-32
pubmed: 3016548

Auteurs

Junfen Shi (J)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Xianyan Hu (X)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Yuan Guo (Y)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Linhan Wang (L)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Jia Ji (J)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Jiqiang Li (J)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Zai-Rong Zhang (ZR)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China zrzhang@sioc.ac.cn.
University of Chinese Academy of Sciences, Shijingshan District, Beijing 100049, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH